ENTRY       D10604                      Drug
NAME        Binimetinib (JAN/USAN/INN);
            Mektovi (TN)
PRODUCT     MEKTOVI (Array BioPharma)
FORMULA     C17H15BrF2N4O3
EXACT_MASS  440.0296
MOL_WEIGHT  441.2268
CLASS       Antineoplastic
             DG03137  MEK inhibitor
REMARK      Therapeutic category: 4291
            ATC code: L01EE03
            Product: D10604<JP/US>
EFFICACY    Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor
  DISEASE   Melanoma (BRAF mutation positive) [DS:H00038]
TARGET      MAP2K1 (MEK1) [HSA:5604] [KO:K04368]
            MAP2K2 (MEK2) [HSA:5605] [KO:K04369]
  PATHWAY   hsa04010(5604+5605)  MAPK signaling pathway
            hsa05200(5604+5605)  Pathways in cancer
            hsa05218(5604+5605)  Melanoma
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EE Mitogen-activated protein kinase (MEK) inhibitors
                 L01EE03 Binimetinib
                  D10604  Binimetinib (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Binimetinib
                D10604  Binimetinib (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D10604  Binimetinib (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG03137  MEK inhibitor
               D10604  Binimetinib
            Drug classes [BR:br08332]
             Antineoplastic
              DG03137  MEK inhibitor
               D10604  Binimetinib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Serine/threonine kinases
               STE group
                MAP2K1 (MEK1)
                 D10604  Binimetinib (JAN/USAN/INN) &lt;JP/US&gt;
                MAP2K2 (MEK2)
                 D10604  Binimetinib (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10604
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10604
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10604
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10604
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D10604
DBLINKS     CAS: 606143-89-9
            PubChem: 254741566
            ChEBI: 145371
            PDB-CCD: QO7
ATOM        27
            1   C8y C    12.9500  -16.7300
            2   C8y C    12.9500  -18.1300
            3   C8x C    14.1624  -18.8300
            4   C8y C    15.3749  -18.1300
            5   C8y C    15.3749  -16.7300
            6   C8y C    14.1624  -16.0300
            7   N4y N    16.7064  -18.5626
            8   C8x C    17.5293  -17.4300
            9   N5x N    16.7064  -16.2974
            10  X   F    14.1624  -14.6302
            11  N1b N    11.7376  -16.0300
            12  C5a C    11.7376  -18.8300
            13  N1b N    10.5421  -18.1396
            14  O5a O    11.7375  -20.2298
            15  O2a O     9.3547  -18.8251
            16  C1b C     8.1635  -18.1371
            17  C1b C     6.9740  -18.8238
            18  O1a O     5.7839  -18.1365
            19  C8y C    11.7375  -14.6302
            20  C8x C    12.9667  -13.9202
            21  C8x C    12.9665  -12.5202
            22  C8y C    11.7539  -11.8204
            23  C8x C    10.5247  -12.5304
            24  C8y C    10.5249  -13.9304
            25  X   Br   11.7538  -10.4300
            26  X   F     9.2942  -14.6414
            27  C1a C    17.1375  -19.8894
BOND        29
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    5   9 1
            11    6  10 1
            12    1  11 1
            13    2  12 1
            14   12  13 1
            15   12  14 2
            16   13  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   11  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 2
            26   19  24 1
            27   22  25 1
            28   24  26 1
            29    7  27 1
///
